4//SEC Filing
Bryce Joanne 4
Accession 0000950170-23-046397
CIK 0001816736other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:16 PM ET
Size
8.5 KB
Accession
0000950170-23-046397
Insider Transaction Report
Form 4
Bryce Joanne
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-09-01−1,000→ 3,753 totalExercise: $2.65Exp: 2030-10-22→ Common Stock (1,000 underlying) - Exercise/Conversion
Common Stock
2023-09-01$2.65/sh+1,000$2,650→ 2,260 total - Sale
Common Stock
2023-09-01$52.99/sh−1,000$52,990→ 1,260 total
Footnotes (2)
- [F1]The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 15, 2023.
- [F2]The shares underlying this option vest in 48 equal monthly installments following October 7, 2020, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Disc Medicine, Inc.
CIK 0001816736
Entity typeother
Related Parties
1- filerCIK 0001951845
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 4:16 PM ET
- Size
- 8.5 KB